Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2641 (LINC02641)

Target
LINC02641
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02641 is a long intergenic non-protein coding RNA gene that produces an RNA molecule greater than 200 nucleotides in length, without protein-coding capacity[1][5][7]. It belongs to the lncRNA/lincRNA family and has no known coding transcript, enzyme, or receptor function. LINC02641, along with several other lncRNAs, has been identified as having predictive prognostic value in hepatocellular carcinoma, where its expression profile is used to classify molecular subtypes with implications for patient prognosis and potential drug sensitivity. Like other lincRNAs, it is likely to influence transcription, chromatin status, and regulatory networks, but its precise molecular mechanism remains largely uncharacterized[2][5][7].

Other names
LINC02641ENSG00000286344105378531
02

Mechanism of action

No mechanism of action is documented in the drug-target sense. Drug sensitivity is correlated with lncRNA expression; mechanisms are likely indirect (e.g., modulation of gene networks by LINC02641 that impact drug response)[2].

03

Biological functions

Regulation of gene expression (particularly nearby genes and pathways)Possible role in cancer-relevant metabolic and signaling pathways, including cell cycle, metabolism, and p53 signalingPotential chromatin and transcriptional remodeling, enhancer-like activity (as generally found for lincRNAs)
04

Disease associations

Cancer (specifically hepatocellular carcinoma in current literature)May serve as a biomarker to stratify prognosis in HCC patients
05

Safety considerations

None identified. LINC02641 is currently studied for its biomarker value, not as a direct therapeutic intervention point, so safety data are not available[2][5][7].
06

Interacting drugs

BI 2536

4 more in the full profile.

07

Biomarkers

LINC02641 expression may serve as a biomarker for prognosis and molecular classification in hepatocellular carcinomaUsed to stratify patients into risk groups and molecular subtypes for clinical prediction

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2641 (LINC02641).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2641 (LINC02641).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call